Loan Capital Changement Date
Acadia Pharmaceuticals USD 0 0 2022-06
Akebia Therapeutics USD 17.18M 17.43M 2023-12
ALKERMES USD 288.37M 635K 2023-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amarin USD 0 0 2022-06
ANI Pharmaceuticals USD 284.82M 213K 2023-12
BioMarin Pharmaceutical USD 593.1M 509K 2023-12
Chimerix USD 0 0 2022-06
Exact Sciences USD 2.32B 455K 2023-12
Exelixis USD 0 0 2022-03
Heron Therapeutics USD 149.44M 52K 2023-09
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Ironwood Pharmaceuticals USD 498.31M 24.83M 2023-12
Lonza CHF 2.46B 907M 2023-06
Merck USD 33.97B 100M 2023-09
Moderna USD 575M 0 2023-12
Myriad Genetics USD 38.5M 0 2023-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 513.8M 2.14M 2023-12
Pfizer USD 61.05B 308M 2023-09
PTC Therapeutics USD 1.92B 673.35M 2023-12
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
United Therapeutics USD 300M 200M 2023-12
Xoma USD 0 0 2022-06



Emergent BioSolutions Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.